Inventor · disambiguated record
Gary T. Wang
Also filed as: WANG GARY · WANG GARY T
44 granted patents·20 pending applications·699 citations·filing 1996–2024
98Inventor score
Top patents by PatentIndex Score
64 records- 0198US8546399B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesBRUNCKO MILAN·Filed 2010·Granted Oct 1, 2013·100 cites·24 claims
- 0297US9174982B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Nov 3, 2015·38 cites·7 claims
- 0397US8586754B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2010·Granted Nov 19, 2013·59 cites·8 claims
- 0497US8580794B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDOHERTY GEORGE A·Filed 2010·Granted Nov 12, 2013·44 cites·3 claims
- 0597US8563735B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesBRUNCKO MILAN·Filed 2009·Granted Oct 22, 2013·72 cites·4 claims
- 0697US8557983B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesDOHERTY GEORGE A·Filed 2010·Granted Oct 15, 2013·44 cites·2 claims
- 0796US9034875B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted May 19, 2015·19 cites·1 claims
- 0896US9029404B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted May 12, 2015·19 cites·1 claims
- 0994US9326508B2(S)-3′-methyl-abscisic acid and esters thereofVALENT BIOSCIENCES CORP·Filed 2015·Granted May 3, 2016·5 cites·9 claims
- 1094US9073855B2BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·2 claims
- 1194US9045420B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jun 2, 2015·11 cites·1 claims
- 1294US7772231B2Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitorsABBOTT LAB·Filed 2006·Granted Aug 10, 2010·68 cites·20 claims
- 1391US9303025B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2014·Granted Apr 5, 2016·11 cites·4 claims
- 1491US8338466B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesKUNZER AARON R·Filed 2010·Granted Dec 25, 2012·15 cites·6 claims
- 1591US6455571B1Inhibitors of neuraminidasesABBOTT LAB·Filed 1999·Granted Sep 24, 2002·60 cites·115 claims
- 1690US9072748B2BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Jul 7, 2015·11 cites·10 claims
- 1790US7491718B2Sulfonamides having antiangiogenic and anticancer activityABBOTT LAB·Filed 2003·Granted Feb 17, 2009·35 cites·3 claims
- 1889US9125913B2Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseasesABBVIE INC·Filed 2013·Granted Sep 8, 2015·10 cites·6 claims
- 1988US9872492B2(S)-abscisic acid derivatives for thinningVALENT BIOSCIENCES CORP·Filed 2016·Granted Jan 23, 2018·2 cites·14 claims
- 2087US9447015B1(S)-2′-vinyl-abscisic acid derivativesVALENT BIOSCIENCES CORP·Filed 2016·Granted Sep 20, 2016·5 cites·30 claims
- 2186US2025019364A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2024·Application pending·0 cites
- 2284US6787542B2Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agentsICOS CORP·Filed 2001·Granted Sep 7, 2004·19 cites·27 claims
- 2383US2024043404A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2023·Application pending·0 cites
- 2482US11897864B2Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2022·Granted Feb 13, 2024·0 cites·27 claims
- 2582US10729135B2Methods of controlling pests using terpendolesVALENT BIOSCIENCES LLC·Filed 2018·Granted Aug 4, 2020·1 cites·6 claims
- 2680US10945443B2Tolypocladium album strainVALENT BIOSCIENCES LLC·Filed 2018·Granted Mar 16, 2021·1 cites·15 claims
- 2780US9877480B2(S)-abscisic acid derivatives for enhanced grape colorationVALENT BIOSCIENCES CORP·Filed 2016·Granted Jan 30, 2018·1 cites·9 claims
- 2879US7323570B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2006·Granted Jan 29, 2008·2 cites·5 claims
- 2975US8354422B2Pyrimidine inhibitors of kinase activityABBOTT LAB·Filed 2010·Granted Jan 15, 2013·2 cites·18 claims
- 3075US2022315555A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2021·Application pending·0 cites
- 3175US2021221789A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2020·Application pending·0 cites
- 3274US8486933B2Pyrimidine inhibitors of kinase activityWANG GARY T·Filed 2010·Granted Jul 16, 2013·3 cites·22 claims
- 3374US6593314B1Neuraminidase inhibitorsABBOTT LAB·Filed 2000·Granted Jul 15, 2003·8 cites·15 claims
- 3473US7211595B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2001·Granted May 1, 2007·5 cites·34 claims
- 3570US2020231566A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2019·Application pending·0 cites
- 3669US7129247B2Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agentsICOS CORP·Filed 2004·Granted Oct 31, 2006·3 cites·26 claims
- 3769US6831096B2Inhibitors of neuraminidasesABBOTT LAB·Filed 2002·Granted Dec 14, 2004·3 cites·9 claims
- 3869US2010160322A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 3968US2019119247A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2018·Application pending·0 cites
- 4066US10299476B23′-substituted-abscisic acid derivativesVALENT BIOSCIENCES LLC·Filed 2017·Granted May 28, 2019·0 cites·1 claims
- 4164US11497214B2Methods of controlling pests using terpendolesVALENT BIOSCIENCES LLC·Filed 2020·Granted Nov 15, 2022·0 cites·11 claims
- 4264US9156856B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2012·Granted Oct 13, 2015·0 cites·6 claims
- 4363US7056925B2Urea kinase inhibitorsABBOTT LAB·Filed 2003·Granted Jun 6, 2006·2 cites·20 claims
- 4463US2017158666A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2016·Application pending·0 cites
- 4563US2024215582A1Methods of controlling plant pathogensVALENT BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
- 4662US2012190688A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesBRUNCKO MILAN·Filed 2012·Application pending·0 cites
- 4761US9051315B2Imidazopyridines as a novel scaffold for multi-targeted kinase inhibitionBA-MAUNG NWE Y·Filed 2010·Granted Jun 9, 2015·1 cites·4 claims
- 4861US2018251426A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 4960US9781930B23′-substituted-abscisic acid derivativesVALENT BIOSCIENCES CORP·Filed 2015·Granted Oct 10, 2017·0 cites·4 claims
- 5059US2015329541A1Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →